BetterScholar BetterScholar
7
Role
Title
Level Year L/R
🐜 Enterocyte loss of polarity and gut wound healing rely upon the F-actin–severing function of villin
12 auth. Florent Ubelmann, M. Chamaillard, Fatima el-Marjou, A. Simon, J. Netter, D. Vignjevic, ... B. Nichols, R. Quezada‐Calvillo, T. Grandjean, D. Louvard, Céline Revenu, S. Robine
6 2013
6
🐜
🐜 Comparison of anal cancer screening strategies including standard anoscopy, anal cytology, and HPV genotyping in HIV-positive men who have sex with men
13 auth. S. Pernot, P. Boucheron, H. Péré, Marie-Laure Lucas, D. Veyer, N. Fathallah, V. de Parades, J. Pavie, J. Netter, L. Collias, ... J. Taieb, S. Grabar, L. Weiss
5 2018
5
🐜
🐜 Clinical implications of CTNNA1 germline mutations in asymptomatic carriers
19 auth. P. Benusiglio, C. Colas, E. Guillerm, Axelle Canard, Hélène Delhomelle, Mathilde Warcoin, J. Bellanger, M. Eyries, M. Zizi, J. Netter, ... F. Soubrier, Y. Parc, A. Mourrégot, Aurélie Maran Gonzalez, V. Cusin, J. Denis, I. Coupier, M. Svrcek, F. Coulet
4 2018
4
🐜
🐜 [Lynch syndrome: What is new?]
9 auth. A. Pellat, J. Netter, G. Perkins, R. Cohen, F. Coulet, Y. Parc, ... M. Svrcek, A. Duval, T. André
4 2019
4
🐜
🦁 Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer.
13 auth. J. Netter, J. Lehmann-Che, J. Lambert, A. Tallet, N. Lourenço, H. Soliman, P. Bertheau, B. Pariente, M. Chirica, M. Pocard, ... M. Allez, H. de Thé, J. Gornet
3 2015
3
🦁
🦁 Advances in management of adjuvant chemotherapy in rectal cancer: Consequences for clinical practice.
J. Netter, R. Douard, C. Durdux, B. Landi, A. Berger, J. Taieb
3 2016
3
🦁
🐬 Early-Onset colorectal Cancer: From the laboratory to the clinic.
A. Gandini, J. Taieb, Hélène Blons, J. Netter, Pierre Laurent-Puig, C. Gallois
2 2024
2
🐬